160 related articles for article (PubMed ID: 19939895)
21. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
[TBL] [Abstract][Full Text] [Related]
22. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
Howard K; Barratt A; Mann GJ; Patel MI
Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
[TBL] [Abstract][Full Text] [Related]
23. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
24. Family history of breast cancer as a predictor for fatal prostate cancer.
Rodríguez C; Calle EE; Tatham LM; Wingo PA; Miracle-McMahill HL; Thun MJ; Heath CW
Epidemiology; 1998 Sep; 9(5):525-9. PubMed ID: 9730031
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age.
Grönberg H; Damber L; Jonson H; Damber JE
Urology; 1997 Mar; 49(3):374-8. PubMed ID: 9123701
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
[TBL] [Abstract][Full Text] [Related]
27. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
Scand J Urol Nephrol; 2005; 39(2):117-23. PubMed ID: 16019764
[TBL] [Abstract][Full Text] [Related]
28. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.
McDowell ME; Occhipinti S; Gardiner RA; Baade PD; Steginga SK
Eur J Cancer Care (Engl); 2009 Nov; 18(6):545-55. PubMed ID: 19686273
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
Psychooncology; 2013 Nov; 22(11):2496-504. PubMed ID: 23712946
[TBL] [Abstract][Full Text] [Related]
30. Risk of breast cancer in families of multiple affected women and men.
Bevier M; Sundquist K; Hemminki K
Breast Cancer Res Treat; 2012 Apr; 132(2):723-8. PubMed ID: 22179927
[TBL] [Abstract][Full Text] [Related]
31. Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer.
Brandt A; Sundquist J; Hemminki K
Br J Dermatol; 2011 Aug; 165(2):342-8. PubMed ID: 21457213
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk.
Hemminki K; Rawal R; Bermejo JL
Int J Cancer; 2005 Jan; 113(2):312-5. PubMed ID: 15386407
[TBL] [Abstract][Full Text] [Related]
33. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members.
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur Urol; 2010 Aug; 58(2):275-80. PubMed ID: 20171779
[TBL] [Abstract][Full Text] [Related]
34. Familial melanoma by histology and age: joint data from five Nordic countries.
Fallah M; Pukkala E; Sundquist K; Tretli S; Olsen JH; Tryggvadottir L; Hemminki K
Eur J Cancer; 2014 Apr; 50(6):1176-83. PubMed ID: 24461199
[TBL] [Abstract][Full Text] [Related]
35. Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden.
Damber L; Grönberg H; Damber JE
Int J Cancer; 1998 Oct; 78(3):293-7. PubMed ID: 9766560
[TBL] [Abstract][Full Text] [Related]
36. Familial risk and familial survival in prostate cancer.
Hemminki K
World J Urol; 2012 Apr; 30(2):143-8. PubMed ID: 22116601
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database.
Roudgari H; Hemminki K; Brandt A; Sundquist J; Fallah M
J Med Genet; 2012 May; 49(5):345-52. PubMed ID: 22581973
[TBL] [Abstract][Full Text] [Related]
38. Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.
Xu X; Kharazmi E; Tian Y; Mukama T; Sundquist K; Sundquist J; Brenner H; Fallah M
PLoS Med; 2021 Jun; 18(6):e1003616. PubMed ID: 34061847
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.
Scosyrev E; Messing EM; Mohile S; Golijanin D; Wu G
Cancer; 2012 Jun; 118(12):3062-70. PubMed ID: 22006014
[TBL] [Abstract][Full Text] [Related]
40. Risk of thyroid cancer in relatives of patients with medullary thyroid carcinoma by age at diagnosis.
Fallah M; Sundquist K; Hemminki K
Endocr Relat Cancer; 2013 Oct; 20(5):717-24. PubMed ID: 23928562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
